Both in Pharmaceuticals
BioAge Labs vs Emergent Biosolutions
Over the past year BIOA returned −6.6% and EBS returned −30.3%; their daily moves had a correlation of 0.07.
BIOA −6.6% EBS −30.3%Growth of $1, one year, split-adjusted
| Metric | BIOA | EBS |
|---|---|---|
| Price | $4.84 | $6.38 |
| Market cap | $222.1M | $327.1M |
| Today | −9.53% | −11.14% |
| 1 month | −40.2% | −9.1% |
| 6 months | −73.8% | −27.6% |
| Year to date | −63.4% | −48.4% |
| 1 year | −14.9% | −33.5% |
| Revenue growth (YoY) | +1.6% | +66.3% |
| Gross margin | 100.0% | 58.6% |
| Net margin | −1064.7% | −76.9% |
| P/E (TTM) | — | — |
| Price / sales | 21.5× | 0.4× |
| Net cash | $318.7M | -$442.1M |
| Dividend yield | — | — |
| Volatility (60d) | 216.5% | 96.9% |
| Short % of float | 10.5% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).